1. Home
  2. CTXR vs SGBX Comparison

CTXR vs SGBX Comparison

Compare CTXR & SGBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • SGBX
  • Stock Information
  • Founded
  • CTXR 2007
  • SGBX 2007
  • Country
  • CTXR United States
  • SGBX United States
  • Employees
  • CTXR N/A
  • SGBX N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • SGBX RETAIL: Building Materials
  • Sector
  • CTXR Health Care
  • SGBX Consumer Discretionary
  • Exchange
  • CTXR Nasdaq
  • SGBX Nasdaq
  • Market Cap
  • CTXR 19.8M
  • SGBX 18.1M
  • IPO Year
  • CTXR N/A
  • SGBX 2017
  • Fundamental
  • Price
  • CTXR $1.49
  • SGBX $3.85
  • Analyst Decision
  • CTXR Buy
  • SGBX
  • Analyst Count
  • CTXR 2
  • SGBX 0
  • Target Price
  • CTXR $6.00
  • SGBX N/A
  • AVG Volume (30 Days)
  • CTXR 570.6K
  • SGBX 18.0M
  • Earning Date
  • CTXR 12-26-2025
  • SGBX 11-14-2025
  • Dividend Yield
  • CTXR N/A
  • SGBX N/A
  • EPS Growth
  • CTXR N/A
  • SGBX N/A
  • EPS
  • CTXR N/A
  • SGBX N/A
  • Revenue
  • CTXR N/A
  • SGBX $3,382,896.00
  • Revenue This Year
  • CTXR N/A
  • SGBX $1,628.82
  • Revenue Next Year
  • CTXR $731.60
  • SGBX N/A
  • P/E Ratio
  • CTXR N/A
  • SGBX N/A
  • Revenue Growth
  • CTXR N/A
  • SGBX N/A
  • 52 Week Low
  • CTXR $0.65
  • SGBX $1.81
  • 52 Week High
  • CTXR $5.95
  • SGBX $122.88
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 59.09
  • SGBX 53.70
  • Support Level
  • CTXR $0.97
  • SGBX $2.72
  • Resistance Level
  • CTXR $1.18
  • SGBX $9.34
  • Average True Range (ATR)
  • CTXR 0.12
  • SGBX 1.36
  • MACD
  • CTXR 0.03
  • SGBX 0.17
  • Stochastic Oscillator
  • CTXR 84.72
  • SGBX 26.74

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About SGBX Safe & Green Holdings Corp.

Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.

Share on Social Networks: